nach oben

Indian Journal of Thoracic and Cardiovascular Surgery

Erschienen in:

13.02.2019 | Review Article

TAVR—present, future, and challenges in developing countries

verfasst von: Ajeet Bana

Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Transcatheter aortic valve replacement (TAVR) has become a well-established therapy for inoperable and high-risk patients of Aortic Stenosis in most of the part of the world. The technological advancements in the hemodynamic performance and design of valve prosthesis and also the data provided by various trials regarding the safety and efficacy of TAVR have widened the scope of TAVR in intermediate and low-risk groups also. The main focus of this review is to discuss the feasibility of TAVR in developing countries. Along with this review, it also gives a detailed outlook of the pros and cons of TAVR along with insight into the future of TAVR and its adoption into the low-risk group.

Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585–95. https://doi.org/10.1016/j.jacc.2013.01.047.CrossRefPubMed

Généreux P, Head SJ, Hahn RH, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36. https://doi.org/10.1016/j.jacc.2012.08.1039.CrossRefPubMed

Waterbury TM, Reeder GS, Pislaru SV, Cabalka AK, Rihal CS, Eleid MF. Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2017;90:870–7. https://doi.org/10.1002/ccd.27224.CrossRefPubMed

Krasopoulos G, Falconieri F, Benedetto U, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg. 2016;11:159.CrossRefPubMedPubMedCentral

Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31. https://doi.org/10.1056/NEJMoa1700456.CrossRefPubMed

Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20. https://doi.org/10.1056/NEJMoa1514616.CrossRef

George I, Guglielmetti LC, Bettinger N, et al. Aortic Valve Annular Sizing: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography. Circ Cardiovasc Imaging 2017;10. pii: e005968. https://doi.org/10.1161/CIRCIMAGING.116.005968.

Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607. https://doi.org/10.1056/NEJMoa1008232.CrossRef

Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98. https://doi.org/10.1056/NEJMoa1103510.CrossRefPubMed

10.

Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37:2252–62. https://doi.org/10.1093/eurheartj/ehw112.CrossRefPubMedPubMedCentral

11.

Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8. https://doi.org/10.1056/NEJMoa1400590.CrossRef

12.

Forrest JK. 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System. Presented at: ACC 17. March 2017, Washington, DC, USA.

13.

Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of Aortic Transcatheter Valves) trial and registry. JACC Cardiovasc Interv. 2015;8:60–9. https://doi.org/10.1016/j.jcin.2014.07.022.CrossRefPubMed

14.

Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5:540–51.CrossRefPubMed

15.

Muñoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. JACC Cardiovasc Interv. 2012;5:533–9.CrossRefPubMed

16.

Guetta V, Goldenberg G, Segev A, et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol. 2011;108:1600–5.CrossRefPubMed

17.

Bagur R, Solo K, Alghofaili S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation: systematic review and meta-analysis. Stroke. 2017;48:1306–15. https://doi.org/10.1161/STROKEAHA.116.015915.CrossRefPubMed

18.

Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016;316:592–601. https://doi.org/10.1001/jama.2016.10302.CrossRefPubMed

19.

Giustino G, Sorrentino S, Mehran R, Faggioni M, Dangas G. Cerebral embolic protection during TAVR: a clinical event meta-analysis. J Am Coll Cardiol. 2017;69:465–6. https://doi.org/10.1016/j.jacc.2016.12.002.CrossRefPubMed

20.

Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015–24. https://doi.org/10.1056/NEJMoa1509233.CrossRefPubMed

21.

Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389:2383–92.CrossRefPubMed

22.

Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33:2403–18. https://doi.org/10.1093/eurheartj/ehs255.CrossRefPubMed

23.

Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55:2413–26. https://doi.org/10.1016/j.jacc.2009.10.085.CrossRef

24.

Alavi SH, Groves EM, Kheradvar A. The effect of transcatheter valve crimping on pericardial leafleats. Ann Thorac Surg. 2014;97:1260–6.CrossRefPubMed

25.

Alavi SH, Ruiz V, Krasieva T, Botvinick EL, Kheradvar A. Characterizing the collagen fiber orientation in pericardial leaflets under mechanical loading conditions. Ann Biomed Eng. 2013;41:547–61.CrossRefPubMed

26.

Daubert MA, Weissman NJ, Hahn RT, et al. Long-term valve performance of TAVR and SAVR: a report from the PARTNER I trial. JACC Cardiovasc Imaging. 2016. https://doi.org/10.1016/j.jcmg.2016.11.004.

27.

Reeves BC, Pike K, Rogers CA, et al. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2). Health Technol Assess. 2016;20:1–260.PubMedPubMedCentral

28.

Généreux P, Cohen DJ, Williams MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63:1100–9. https://doi.org/10.1016/j.jacc.2013.10.058.CrossRefPubMed

29.

Généreux P, Cohen DJ, Mack M, et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;64:2605–15. https://doi.org/10.1016/j.jacc.2014.08.052.CrossRefPubMed

30.

Najjar M, Yerebakan H, Sorabella RA, et al. Acute kidney injury following surgical aortic valve replacement. J Card Surg. 2015;30:631–9. https://doi.org/10.1111/jocs.12586.CrossRefPubMedPubMedCentral

31.

Thourani VH, Kodali SK, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25. https://doi.org/10.1016/S0140-6736(16)30073-3.CrossRefPubMed

32.

Langer NB, Hamid NB, Nazif TM, et al. Injuries to the aorta, aortic annulus, and left ventricle during transcatheter aortic valve replacement: management and outcomes. Circ Cardiovasc Interv. 2017;10. pii: e004735. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004735.

33.

Kim WK, Hamm CW. The future of TAVI. Eur Heart J. 2017;38:2704–7.CrossRefPubMed

34.

Yoon SH, Lefèvre T, Ahn JM, et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J Am Coll Cardiol. 2016;68:1195–205.CrossRefPubMed

35.

Ueshima D, Fovino LN, DÁmico G, Brener SJ, Esposito G, Tarantini G. Transcatheter versus surgical aortic valve replacement in low- and intermediate – risk patients : an updated systematic review and meta-analysis. Cardiovasc Interv Ther. 2018. https://doi.org/10.1007/s12928-018-0546-5.

36.

Ruge H, Lange R, Bleiziffer S, et al. First successful aortic valve implantation with the CoreValveReValving System via right subclavian artery access: a case report. Heart Surg Forum. 2008;11:E323–4.CrossRefPubMed

37.

Bauernschmitt R, Schreiber C, Bleiziffer S, et al. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. Heart Surg Forum. 2009;12:E63–4.CrossRefPubMed

38.

Rougé A, Huttin O, Aslam R, et al. Mid-term results of 150 TAVI comparing apical versus femoral approaches. J Cardiothorac Surg. 2015;10:147.CrossRefPubMedPubMedCentral

39.

Wenaweser P, Stortecky S, Heg D, et al. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention. 2014;10:982–9.CrossRefPubMed

40.

Modine T, Sudre A, Delhaye C, et al. Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes. Ann Thorac Surg. 2012;93:1489–94.CrossRefPubMed

41.

Bickler SN, Weiser TG, Kassebaum N, et al. Global burden of surgical conditions. In: Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN, editors. Essential surgery: disease control priorities, vol. 1. 3rd ed. Washington, DC: World Bank; 2015. p. 19–40.CrossRef

42.

Akenroye AT, Stack AM. The development and evaluation of an evidence-based guideline programme to improve care in a paediatric emergency department. Emerg Med J. 2016;33:109–17.CrossRefPubMed

43.

Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372:139–44.CrossRefPubMed

44.

Frost LJ, Reich MR. Creating access to health technologies in poor countries. In: Parker R, Sommer M, editors. Routledge handbook of global public health. New York: Routledge; 2011. chap. 36.

45.

Bergmann T, Sengupta PP, Narula J. Is TAVR ready for the global aging population? Glob Heart. 2017;12:291–9.CrossRefPubMed

46.

World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva: WHO; 2007.

47.

Mishra S. Will percutaneous valves replace the surgical valves: another one bites the dust? Indian Heart J. 2016;68:249–51.CrossRefPubMedPubMedCentral

48.

McDermott FD, Kelly ME, Warwick A, et al. Problems and solutions in delivering global surgery in the 21st century. Br J Surg. 2016;103:165–9.CrossRefPubMed

49.

Nutley T, Reynolds HW. Improving the use of health data for health system strengthening. Glob Health Action. 2013;6:20001.CrossRefPubMed

50.

Elder G, Murphy RA, Herard P, Dilworth K, Olson D, Heinzelmann A. Challenging the barriers to accessing surgery in low-resource settings: lessons learned from burns. Surgery. 2015;158:33–6.CrossRefPubMed

51.

Ruparelia N, Prendergast BD. TAVI in 2015: who, where and how? Heart. 2015;101:1422–31.CrossRefPubMed

52.

Roemer JE, Pedro RD. Barefoot and footloose doctors: optimal resource allocation in developing countries with medical migration. Soc Choice Welf. 2016;46:335–58.CrossRef

53.

Nagarajan N, Varadaraj V. Helping meet surgical needs in under-resourced settings: the role of task shifting. JAMA Surg. 2015;150:687–8.CrossRefPubMed

54.

Stuart C. The lowdown on TAVR: as risk drops, expectations rise. Cardiovascular Business. Available at: http://www.cardiovascularbusiness.com/topics/structural-heart/lowdown-tavr-riskdrops-expectations-rise?nopaging¼1. Accessed 3 Apr 2016.

55.

Mandrola J. TAVR costs put cardiologists in a tough spot. Medscape. Available at: www.medscape.com/viewarticle/856937. Accessed 3 Apr 2016.

56.

Arsalan M, Ballard A, MacLachlan CR, et al. Comparison of current costs and reimbursement for transcatheter and surgical aortic valve replacement. J Am Coll Cardiol. 2016;67:10.CrossRef

57.

Coylewright M, Mack MJ, Holmes DR Jr, O'Gara PT. A call for an evidence-based approach to the heart team for patients with severe aortic stenosis. J Am Coll Cardiol. 2015;65:1472–80.CrossRefPubMed

Titel: TAVR—present, future, and challenges in developing countries
verfasst von: Ajeet Bana
Publikationsdatum: 13.02.2019
Verlag: Springer Singapore
Erschienen in: Indian Journal of Thoracic and Cardiovascular Surgery / Ausgabe 3/2019
Print ISSN: 0970-9134
Elektronische ISSN: 0973-7723
DOI: https://doi.org/10.1007/s12055-018-00786-8

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

TAVR—present, future, and challenges in developing countries

Abstract

Neu im Fachgebiet Chirurgie

Hochrisiko-Eingriffe für postoperative Übelkeit

HNO-Op. auch mit über 90?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Double snaring of superior vena cava

Papillary thyroid carcinoma plunging in the right middle mediastinum

Early and late mortality and morbidity after post-MI ventricular septal rupture repair: predictors, strategies, and results

A composite right atrial colossus excision with atrial reconstruction via thoracotomy—an alternative approach

A new 'Dawn' needed!

Pneumopericardium: a rare complication following pericardiocentesis

Neu im Fachgebiet Chirurgie

Hochrisiko-Eingriffe für postoperative Übelkeit

HNO-Op. auch mit über 90?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“